Glenmark Pharma Shares Surge 2.4% After Initial Dip, Defying Market Trends

Glenmark Pharmaceuticals Ltd (GLEN.NS) shares rebounded on Monday, February 17, 2025, rising 2.4% to ₹1,577.11 after opening lower. This positive turn comes amid broader market volatility and follows the company's recent strong Q3 FY25 results. Glenmark's performance stands out in the pharmaceutical sector, with the stock showing resilience despite recent fluctuations. The company's shares have seen significant growth over the past year, up 73.04% from February 2024. Analysts remain optimistic about Glenmark's prospects, citing its diverse product portfolio and expanding global presence as key growth drivers.

 

Sources: Yahoo Finance, Financial Express, Moneycontrol